This website places cookies on your device to help us improve our service to you. To find out more, see our Privacy and Cookies statement.

Skip to page content

Human Papillomavirus

The HPV programme

Changes to the Human papillomavirus (HPV) vaccine schedule 2014/15 following the move to two-dose schedule - An update for Registered Healthcare Practitioners

CMO Letter Human Papillomavirus (HPV)Vaccination Programme - Change in Schedule from 3 to 2 Doses

The human papillomavirus (HPV) national childhood vaccination programme was introduced in 2008 for girls in S2 at secondary school (12 to 13 years of age) as a three-dose schedule given within a six-month period.

In March 2014, the Joint Committee on Vaccination and Immunisation (JCVI) revised its existing recommendation on the HPV vaccination programme for adolescent girls to change from a three-dose to a two-dose schedule. Emerging evidence from evaluations of the programme around the world has shown that the number of young women with pre-cancerous lesions is falling and all the current indications are that this protection will last for many years. More recent research shows that the antibody levels provided by two doses of the vaccine in young adolescent girls is very good and therefore protection from this schedule is also likely to be long lasting.

In order to support the changes, NES/HPS have developed training slides, notes and FAQs for registered healthcare practitioners.  These can be accessed at the links below.

Dr Kevin Pollock presents a short webinar highlighting the The impact of the HPV vaccine in Scotland - a changing landscape (external Vimeo site) MP4 Version

Please note:  These educational resources continue to be updated as required to support this programme but do not replace the clinical judgement of practitioners. Practitioners should refer to the Public Health England Green Book Chapter when administering the vaccine.

Training Slides- Human Papillomavirus (HPV) 2017 (O365 - read only)
Training Slides with notes- Human Papillomavirus (HPV) 2017 (PDF)
FAQs- Human Papillomavirus (HPV)(PDF)
Webinar highlighting the The impact of the HPV vaccine in Scotland - a changing landscape (external Vimeo site) or MP4 Version
Factsheet- Human Papillomavirus (HPV)(PDF)